Compare Kohl's Corporation (KSS) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kohl's Corporation vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? Kohl's Corporation trades at $21.15 (market cap $2.40B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $38.04 (market cap $63.89B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 26.6× Kohl's Corporation's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays the higher dividend (2.47%). Which is the better fit depends on your goals.
| KSS | RELX | |
|---|---|---|
Market Cap | $2.40B | $63.89B |
Volume | 3,788,378 | 2,760,502 |
Sector | Consumer Cyclical | Industrials |
52-Week High | $24.71 | $46.80 |
52-Week Low | $11.72 | $27.73 |
Typical Hold Time | 48 Days | — |
Enterprise Value | $8.00B | $75.40B |
Dividend Yield | 2.36% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kohl's (KSS) trades at $21.10, down 0.33% on the day, with a bullish technical signal from moving averages and a low valuation profile (P/E 9.06, P/S 0.16). Recent earnings beats in Q4 2025 and Q1-Q2 2026, alongside a raised full-year outlook, highlight improving operational momentum, though revenue has declined from $19.4B in 2022 to $16.2B in 2025. The company maintains a dividend, with the next payment of $0.13 scheduled for September 23, 2026.
The stock presents a value opportunity with attractive multiples and positive earnings surprises, but faces headwinds from 18 consecutive quarters of sales declines and competitive pressures. Analyst sentiment is mixed with a 30% buy rating, and the consensus price target of $15.50 implies downside risk from current levels. Execution on holiday sales and margin stabilization are critical for sustaining the recent rebound.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kohl's Corporation
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
